Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study
- PMID: 34252157
- PMCID: PMC8274847
- DOI: 10.1371/journal.pone.0254523
Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study
Abstract
Background: Longer-term consequences after SARS-CoV-2 infection are becoming an important burden to societies and healthcare systems. Data on post-COVID-19 syndrome in the general population are required for the timely planning of healthcare services and resources. The objective of this study was to assess the prevalence of impaired health status and physical and mental health symptoms among individuals at least six months after SARS-CoV-2 infection, and to characterize their healthcare utilization.
Methods: This population-based prospective cohort study (Zurich SARS-CoV-2 Cohort) enrolled 431 adults from the general population with polymerase chain reaction-confirmed SARS-CoV-2 infection reported to health authorities between 27 February 2020 and 05 August 2020 in the Canton of Zurich, Switzerland. We evaluated the proportion of individuals reporting not to have fully recovered since SARS-CoV-2 infection, and the proportion reporting fatigue (Fatigue Assessment Scale), dyspnea (mMRC dyspnea scale) or depression (DASS-21) at six to eight months after diagnosis. Furthermore, the proportion of individuals with at least one healthcare contact after their acute illness was evaluated. Multivariable logistic regression models were used to assess factors associated with these main outcomes.
Results: Symptoms were present in 385 (89%) participants at diagnosis and 81 (19%) were initially hospitalized. At six to eight months, 111 (26%) reported not having fully recovered. 233 (55%) participants reported symptoms of fatigue, 96 (25%) had at least grade 1 dyspnea, and 111 (26%) had DASS-21 scores indicating symptoms of depression. 170 (40%) participants reported at least one general practitioner visit related to COVID-19 after acute illness, and 10% (8/81) of initially hospitalized individuals were rehospitalized. Individuals that have not fully recovered or suffer from fatigue, dyspnea or depression were more likely to have further healthcare contacts. However, a third of individuals (37/111) that have not fully recovered did not seek further care.
Conclusions: In this population-based study, a relevant proportion of participants suffered from longer-term consequences after SARS-CoV-2 infection. With millions infected across the world, our findings emphasize the need for the timely planning of resources and patient-centered services for post-COVID-19 care.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8274847/bin/pone.0254523.g001.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8274847/bin/pone.0254523.g002.gif)
![Fig 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8274847/bin/pone.0254523.g003.gif)
Similar articles
-
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study.BMJ. 2023 May 31;381:e074425. doi: 10.1136/bmj-2022-074425. BMJ. 2023. PMID: 37257891 Free PMC article.
-
Longitudinal course and predictors of health-related quality of life, mental health, and fatigue, in non-hospitalized individuals with or without post COVID-19 syndrome.Health Qual Life Outcomes. 2024 Apr 14;22(1):32. doi: 10.1186/s12955-024-02245-y. Health Qual Life Outcomes. 2024. PMID: 38616282 Free PMC article.
-
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931. JAMA. 2022. PMID: 36215063 Free PMC article.
-
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.Clin Microbiol Infect. 2022 May;28(5):657-666. doi: 10.1016/j.cmi.2022.01.014. Epub 2022 Feb 3. Clin Microbiol Infect. 2022. PMID: 35124265 Free PMC article. Review.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article. Review.
Cited by
-
Long COVID: cognitive, balance, and retina manifestations.Front Med (Lausanne). 2024 Jul 5;11:1399145. doi: 10.3389/fmed.2024.1399145. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39036098 Free PMC article.
-
Prevalence and determinants of post-COVID-19 syndrome among patients 6 months post-discharge from a teaching hospital in South India.J Family Med Prim Care. 2024 Apr;13(4):1454-1459. doi: 10.4103/jfmpc.jfmpc_1616_23. Epub 2024 Apr 22. J Family Med Prim Care. 2024. PMID: 38827678 Free PMC article.
-
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095. Diseases. 2024. PMID: 38785750 Free PMC article. Review.
-
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols.Inflammopharmacology. 2024 May 21. doi: 10.1007/s10787-024-01483-2. Online ahead of print. Inflammopharmacology. 2024. PMID: 38771409 Review.
-
Incidence and risk factors of post COVID-19 syndrome: a Tunisian cohort study.BMC Infect Dis. 2024 May 1;24(1):461. doi: 10.1186/s12879-023-08949-8. BMC Infect Dis. 2024. PMID: 38693500 Free PMC article.
References
-
- World Health Organization (WHO). Coronavirus Disease (COVID-19) Situation Reports: Weekly Epidemiological Update 23 February 2021. [cited 25 Feb 2021]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...
-
- National Institute for Health Research (NIHR). Living with Covid19. 15 Oct 2020. [cited 25 Jan 2021].
-
- National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE; 2020. [cited 19 Jan 2021]. https://www.nice.org.uk/guidance/ng188 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous